¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Cowdry type B inclusion bodies"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cell inclusion
    ¼¼Æ÷Æ÷ÇÔ¹°, ¼¼Æ÷ºÀÀÔü
  • epidermal inclusion cyst
    Ç¥ÇǺÀÀÔ³¶, Ç¥ÇÇÆ÷ÇÔ³¶
  • germinal inclusion cyst
    ¹è»óÇǺÀÀÔ³¶, ¹è»óÇÇÆ÷ÇÔ¹°³¶
  • hyaline inclusion
    À¯¸®ÁúÆ÷ÇÔ¹°, À¯¸®ÁúºÀÀÔü
  • inclusion
    1. Æ÷ÇÔ¹°, ºÀÀÔü 2. ºÀÀÔ
  • inclusion blennorrhea
    ºÀÀÔü°í¸§´«¹°, ºÀÀÔü³ó·ç
  • inclusion body
    Æ÷ÇÔü, ºÀÀÔü
  • inclusion body fibromatosis
    Æ÷ÇÔü¼¶À¯Á¾Áõ, ºÀÀÔü¼¶À¯Á¾Áõ
  • inclusion cast
    Æ÷ÇÔü¿øÁÖ
  • inclusion cyst
    Æ÷ÇÔ¹°³¶, ºÀÀÔ³¶
  • inclusion disease
    Æ÷ÇÔüº´, ºÀÀÔüº´
  • inclusion/exclusion criteria
    Æ÷ÇÔÁ¦¿Ü±âÁØ
  • intracellular inclusion body
    ¼¼Æ÷³»Æ÷ÇÔü, ¼¼Æ÷³»ºÀÀÔü
  • intranuclear inclusion body
    ÇÙÆ÷ÇÔü, ÇÙ³»ºÀÀÔü
  • viral inclusion
    ¹ÙÀÌ·¯½ºÆ÷ÇÔ¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inclusion body fibromatosis
    Æ÷ÇÔü¼¶À¯Á¾Áõ
  • hyaline inclusion
    À¯¸®ÁúÆ÷ÇÔ¹°, À¯¸®ÁúºÀÀÔü
  • inclusion
    Æ÷ÇÔ¹°
  • viral inclusion
    ¹ÙÀÌ·¯½ºÆ÷ÇÔ¹°
  • abortive type
    ºÎÀüÇü
  • anovulatory type
    ¹«¹è¶õÇü
  • asthenic type
    ¹«·ÂüÇü
  • athletic type
    °ÇÀåÇü
  • precision type attachment
    Á¤¹ÐÇüºÎÂø
  • type specific antigen
    ÇüƯÀÌÇ׿ø
  • blood type
    Ç÷¾×Çü
  • bubble type vaporizer
    ±âÆ÷Çü±âÈ­±â
  • cellular type
    ¼¼Æ÷Çü
  • culture type
    Ç¥ÁرÕÁÖ, ±âÁØÁÖ
  • linear type constitution
    ¼±ÇüüÇü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inclusion body, intracytoplasmic
    ¼¼Æ÷³»ºÀÀÔü
  • inclusion cast
    ºÀÀÔü¿øÁÖ
  • inclusion conjunctivities
    ºÀÀÔü °á¸·¿°(¡­Ì¿Ø¯æú)
  • inclusion conjunctivitis
    ºÀÀÔü°á¸·¿°
  • inclusion conjunctivitis
    ºÀÀÔü °á¸·¿°
  • inclusion conjunctivitis
    ºÀÀÔü°á¸·¿°.
  • primary inclusion
    ÀÏÂ÷ºÀÀÔü(ÀÏÂ÷ºÀÀÔü).
  • B type virus particle
    BÇü ¹ÙÀÌ·¯½ºÀÔÀÚ.
  • B type virus particle
    BÇü ¹ÙÀÌ·¯½ºÀÔÀÚ.
  • C type particle
    CÇüÀÔÀÚ
  • C-type particle
    CÇü ÀÔÀÚ (·¹Æ®·Î¹ÙÀÌ·¯½ºÀÇ)
  • C-type virus particle
    CÇü ¹ÙÀÌ·¯½ºÀÔÀÚ.
  • Charcot-Marie type
    »þ¸£ÄÚ-¸¶¸®Çü.
  • Duchenne-Landouzy type
    µÚ½Ã¿£´À-¶õµÎ¿ìÁöÇü.
  • Gougerot-Ruiter type vasculitis
    ±¸Á¦·Î ·çÀÌÅÍ Çü Ç÷°ü¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • picks bodies
    ÇÇÅ©¼Òü(¡­á´ô÷)
  • quadrigeminal bodies
    ȍ
  • quadrigeminal bodies
    »ç±¸Ã¼(ÞÌÎøô÷).
  • removal of foreign bodies in root canal
    ±Ù°ü³»À̹°Á¦°Å¹ý(ÐÆÎ·Ò®ì¶Úªð¶ËÛ Ûö).
  • rheumatic fever,aschoff bodies
    ¾Æ¼îÇÁ¼Òü(¾Æ¼îÇÁ á³ô÷)
  • sickel cell disease,gandy gamna bodies
    °µµð°¨³ª¼Òü(¡­á³ô÷)
  • acute inclusion body encephalitis
    ±Þ¼º ºÀÀÔü³ú¿°(¡­Üæìýô÷Òàæú).
  • body, inclusion
    ºÀÀÔü
  • conjunctivits, inclusion
    ºÀÀÔü °á¸·¿°
  • crystalloid inclusion
    °áÁ¤Æ÷ÇÔ¹°
  • cytomegalic inclusion
    °Å´ë¼¼Æ÷ºÀÀÔü(ËÝÓÞá¬øàÜæìýô÷)
  • cytomegalic inclusion disease
    ¼¼Æ÷ °Å´ë ºÀÀÔü º´
  • cytomegalic inclusion disease
    ¼¼Æ÷°Å´ëÈ­ ºÀÀÔüº´
  • cytomegalic inclusion disease =CID
    ¼¼Æ÷°Å´ë¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =CID
    ¼¼Æ÷°Å´ë¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Type A spermatogonium
    À¸¶äÁ¤Á¶¼¼Æ÷
    [¿¾ ¿ë¾î] AÁ¤Á¶¼¼Æ÷
  • Type I hair cell
    Á¶·Õ¹ÚÅм¼Æ÷
    [¿¾ ¿ë¾î] ¹è»ó¿¬Á¢¼¼Æ÷
  • Elastic type of artery
    ź·ÂÇüµ¿¸Æ
    [¿¾ ¿ë¾î] ź·ÂÇüµ¿¸Æ
  • Glomus type of arteriovenous anastomosis
    Å丮Çüµ¿Á¤¸Æ¿¬°á
    [¿¾ ¿ë¾î] ±¸Çüµ¿Á¤¸Æ¹®ÇÕ
  • Mixed type of artery
    È¥ÇÕÇüµ¿¸Æ
    [¿¾ ¿ë¾î] È¥ÇÕÇüµ¿¸Æ
  • Chief cell [Type I glomus cell]
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁÖ¼¼Æ÷
  • Pneumocyte type II
    °ú¸³ÇãÆÄ²Ê¸®¼¼Æ÷
    [¿¾ ¿ë¾î] ´ëÆóÆ÷¼¼Æ÷
  • Golgi type I neuron
    ±äÃà»è½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ÀåÃà»è´Ù±Ø½Å°æ¿ø
  • Supporting cell [Type II glomus cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁö¼¼Æ÷
  • Supporting cell [Type II glomus cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁö¼¼Æ÷(Á¦2Çü»ç±¸¼¼Æ÷)
  • Hypertrophic type
    ºñ´ëÇü
    [¿¾ ¿ë¾î] ºñ´ëÇü
  • Fibrous type of vein
    ¼¶À¯ÇüÁ¤¸Æ
    [¿¾ ¿ë¾î] ¼¶À¯ÇüÁ¤¸Æ
  • Golgi type II neuron
    ªÀºÃà»è½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ´ÜÃà»è´Ù±Ø½Å°æ¿ø
  • Pneumocyte type I
    È£ÈíÇãÆÄ²Ê¸®¼¼Æ÷
    [¿¾ ¿ë¾î] È£Èí»óÇǼ¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • type B RNA virus
    BÇü(úþ) RNA ¹ÙÀÌ·¯½º
  • type C virus
    CÇü(úþ) ¹ÙÀÌ·¯½º
  • type C RNA virus
    CÇü(úþ) RNA ¹ÙÀÌ·¯½º
  • type I error
    IÇü(úþ) ¿ÀÂ÷(è¦ó¬)
  • type II error
    IIÇü(úþ) ¿ÀÂ÷(è¦ó¬)
  • type I immunoglobulin
    IÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type II immunoglobulin
    IIÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type K immunoglobulin
    KÇü(úþ) ¸é¿ª(Øóæ¹) ±Û·ÎºÒ¸°
  • type L immunoglobulin
    LÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type-specific antigen
    ÇüƯÀÌ Ç׿ø(úþ÷åì¶ù÷ê«)
  • Watson-Crick-type DNA
    ¿Ó½¼-Å©¸¯Çü(úþ) DNA
  • wild-type
    ¾ß»ýÇü(å¯ßæúþ)
  • wild-type allele
    ¾ß»ýÇü(å¯ßæúþ) ´ë¸³(Óߨ¡)À¯ÀüÀÚ(ë¶îîí­)
  • wild-type gene
    ¾ß»ýÇü(å¯ßæúþ) À¯ÀüÀÚ(ë¶îîí­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ASAB Anti-Sperm Anti-Bodies
HJ Howell-Jolly [bodies]
P/I/X patients, indicators, external bodies
UFB urinary fat bodies
NF Neuro-Fibromatosis
  = Von Recklinghausen's Disease
  NF 1; Neuro-Fibroma...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LBHI Lewy body-like hyaline inclusion
S-IBM Sporadic inclusion body myositis
CI cylindrical inclusion
IFU inclusion forming units
NI nuclear inclusion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Leishman-Donovan bodies
    ·¹½´¸¸-µµ³ë¹Ýü
    Ä®¶ó-¾ÆÀÚ¸£ º´¿¡ °É¸° ȯÀÚÀÇ Æ¯È÷ ºñÀå°ú °£ÀÇ ¼¼¸Á ³»ÇÇ ¼¼Æ÷ ³»¿¡¼­ °üÂûµÇ´Â ±¸Çü ¶Ç´Â ³­ÇüÀÇ ¼Òü·Î¼­, ÀÌ º´À» ÀÏÀ¸Å°´Â ±â»ýÃæÀÎ ¿ø»ýµ¿¹°ÀÇ ¹«Æí¸ð ¼¼Æ÷ ³»¿¡ ÀÖ´Ù. ¶ÇÇÑ ÇǺμº ·¹½´¸¶´Ï¾ÆÁõ¿¡¼­ ´ë½Ä ¼¼Æ÷³»¿¡¼­µµ °üÂûµÈ´Ù. L. tro
  • Mooser bodies
    ¹«¿ì¼­ ¼Òü
    ¹ßÁøÆ¼Çª½ºÀÇ ¾î¶² Çü¿¡ À־ Ãʸ· »óÇÇ ¼¼Æ÷ÀÇ »ïÃâ¾×¿¡¼­ °üÂûµÇ´Â ¸®ÄÉÄ¡¾Æ ¸ð¾çÀÇ ¼Òü.
  • Nissl bodies
    ´Ï½½ ¼Òü
    »ö¼Ò ģȭü, ŸÀ̱׷ÎÀÌµå ¹°Áú, Ç¥¹® ¹°Áú. ¿°±â¼º ¿°·á·Î ¿°»öµÇ°í, ³»ÇüÁú ¼¼¸Á°ú ¶óÀ̺¸¼ØÀ¸·Î ±¸¼ºµÈ ½Å°æ ¼¼Æ÷³»ÀÇ Ä¿´Ù¶õ °ú¸³.
  • purine bodies test
    Ǫ¸°Ã¼ ½ÃÇè
  • rice bodies
    ¹Ì¸³Ã¼
    °üÀý°ÇÀ̳ª ¼öȰ¾× ³¶Á¾¾× ¼Ó¿¡ Çü¼ºµÇ´Â ¹Ì¸³»óÀÇ ¼Òü.
  • Schaumann's bodies
    »þÀ¯¸¸Ã¼
    Àû»öÀÌ µµ´Â °¥»öÀÇ °áÀý»ó ¶Ç´Â Á¶°³ ¸ð¾çÀÇ »ç¸£ÄÚÀ̵µ½Ã½º º´º¯¿¡¼­ °üÂûÇÒ ¼ö ÀÖ´Â ¼Òü.
  • ultimobranchial bodies
    ÈÄ»õü
    Á¦ 5Àεγ¶ ȤÀº »õ³¶ÀÇ ¹èÀ¯µµÃ¼·Î¼­, ºÎ°©»ó¼±À» ¿¬ÇÏ¿© °©»ó¼±°ú À¶ÇÕÇÑ´Ù.
  • vermiform bodies
    Ãæ¾ç ¼Òü
    °£ÀÇ ÄíÆÛ ¼¼Æ÷¿¡¼­ º¼ ¼ö ÀÖ´Â ¼¼Æ÷¸·ÀÇ Æ¯ÀÌÇÑ µ¿ ¸ð¾çÀÇ ÇÔ¸ô·Î¼­ ÆòÇื°ú Èñ¹ÌÇÑ È¾¹® »çÀÌ¿¡ Áß¾Ó ¼±»ó ±¸Á¶¸¦ °¡Áö°í ÀÖ´Ù. ÀÌ¿Í À¯»çÇÑ ±¸Á¶¸¦ ¾î¶² Àå±â³»ÀÇ ´ë½Ä¼¼Æ÷¿Í Ç¥ÇÇÀÇ ¶û°Ô¸£Çѽº ¼¼Æ÷¿¡¼­µµ °üÂûÇÒ ¼ö ÀÖ´Ù.
  • abortive type
    ºÎÀüÇü
  • adenoid type
    ¼±¾ç
  • Bamberger's type
    ¸¸¼º ´Ù¹ß¼º À帷¿°
  • bilateral type
    ¾çÃøÇü
  • blood type
    Ç÷¾×Çü
  • body type
    üÇü
    ¸öÀÇ »ý±è»ý±è.
  • brush type vessel arrangement
    ¼Ö ¸ð¾çÀÇ Ç÷°ü ¹è¿­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
inclusion body disease <disease> An illness in newborns caused by viral infection, symptoms includefever, cellular enlargement, microscopically-visible clumps of viralparticles or proteins in the cytoplasm and nuclei of affected cells, enlargementof the spleen and liver. Long-term effects of the disease may includemental retardation.
(09 Oct 1997)
inclusion body encephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
inclusion body myositis <radiology> Common form of inflamatory myopathy, most common in the elderly, equal sex incidence, sporadic idiopathic disease (very rarely familial), misdiagnosed as steroid-resistant polymyositis symptoms, presents as a painless slowly progressive proximal myopathy, may cause dysphagia, mild to moderate muscle wasting diagnosis, serum creatine kinase levels usually normal or only slightly elevated, EMG may show non-specific myopathic features, diagnosis on muscle biopsy, inclusion bodies seen in rimmed vacuoles in skeletal muscle fibres treatment, steroids and immunosuppression generally ineffective, rare patients reported who have made a response to treatment pathogenesis, unknown, ubiquitin, prion protein, tau protein found in inclusions, abnormal mitchondria seen in some case
(12 Dec 1998)
inclusion body rhinitis A respiratory disease of pigs caused by the cytomegalovirus porcine herpesvirus 2 and characterised by rhinitis and conjunctivitis in young pigs.
(05 Mar 2000)
inclusion cell i cell
inclusion cell disease <biochemistry> Mucolipidosis of early onset and with severe symptoms like those in Hurler's syndrome but with normal urinary mucopolysaccharides, vacuolated lymphocytes, and inclusion bodies in cultured fibroblasts (I-cells).
The lysosomes lack hydrolases but high concentrations of lysosomal enzymes are found in the extracellular fluids such as serum, spinal fluid, and urine.
It is associated with a deficiency of N-acetylglucosaminyl-1-phosphotransferase. The gene defect responsible probably prevents the addition of the lysosome recognition marker mannose 6 phosphate) to these enzymes so that they are not directed into the lysosomes but are released.
Inheritance: autosomal recessive.
Synonym: I-cell disease, inclusion cell disease.
(12 Jul 2000)
inclusion compound The mechanical trapping of small molecules within spaces between other molecules; e.g., the inclusion of iodine molecules by starch molecules to form the well-known red-to-black "addition compound"
(05 Mar 2000)
inclusion conjunctivitis A follicular conjunctivitis caused by Chlamydia trachomatis.
(05 Mar 2000)
inclusion conjunctivitis viruses Former name for Chlamydia trachomatis.
(05 Mar 2000)
inclusion cyst Intradermal or subcutaneous saclike structure, the wall of which is stratified epithelium containing keratohyalin granules.
(12 Dec 1998)
inclusion dermoid A collection of cancerous cells which form cysts that contain one or more of the three primary embryonic germ layers: skin, hair or teeth.
(27 Sep 1997)
epidermoid inclusion cyst <radiology> Well-circumscribed radiolucent lesion showing a thin cortical margin that may not be visible in its entirety, frequently in the terminal phalanx, history of penetrating trauma is often elicited Differential diagnosis: ABC, enchondroma
(12 Dec 1998)
foetal inclusion Unequal conjoined twins in which the incompletely developed parasite is wholly enclosed in the autosite.
(05 Mar 2000)
alcoholic hyaline bodies Large, poorly defined accumulations of eosinophilic material in the cytoplasm of damaged hepatic cells in certain forms of cirrhosis and marked fatty change especially due to alcoholism.
Synonym: alcoholic hyalin, alcoholic hyaline bodies.
(05 Mar 2000)
Alder bodies Granular inclusions in polymorphonuclear leukocytes; they take on a dark colour with Giemsa-Wright stain and react metachromatically with toluidine blue.
See: Alder's anomaly.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ideal type
    ÀÌ»óÇü
  • italic type
    (ÀÎ)ÀÌÅÚ¸¯Ã¼;»çü
  • moon type
    (¸ÍÀοëÀÇ)¹®½Ä¼±ÀÚ
  • repulsive(-type) maglev
    ¹Ý¹ß½Ä Àڱ⠺λó(Â÷ü¸¦ ¶ß°ÔÇϱâ À§ÇØ ÀüÀÚ¼®ÀÇ ¹Ý¹ß·ÂÀ» ÀÌ¿ë)
  • type
    Çü;À¯Çü;¾ç½Ä;ÀüÇü;°ßº»;Ç¥;ȰÀÚ;Ç÷¾×Çü;in ~ ȰÀڷΠ§(Â¥¼­);set ~ Á¶ÆÇÇÏ´Ù
  • type
    ŸÀÌÇÁ¶óÀÌÅÍ·Î Âï´Ù;(Ç÷¾×)ÇüÀ» °Ë»çÇÏ´Ù;»ó¡ÇÏ´Ù;...ÀÇ ÀüÇüÀÌ µÇ´Ù
  • type cast
    (±ØÁß Àι°ÀÇ ½ÅÀå,¸ñ¼Ò¸® µûÀ§¿¡ ¸Â´Â) ¹è¿ì¸¦ ¹è¿ªÇÏ´Ù
  • type founder
    ȰÀÚ ÁÖÁ¶°ø(¾÷ÀÚ)
  • type metal
    ȰÀÚ ÇÕ±Ý
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á